Xiaofeng Chen

604 total citations
12 papers, 514 citations indexed

About

Xiaofeng Chen is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Xiaofeng Chen has authored 12 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 10 papers in Molecular Biology and 1 paper in Surgery. Recurrent topics in Xiaofeng Chen's work include MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (7 papers). Xiaofeng Chen is often cited by papers focused on MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (7 papers). Xiaofeng Chen collaborates with scholars based in China, Saudi Arabia and United States. Xiaofeng Chen's co-authors include Mingchuan Zhao, Heyong Wang, Rong Wang, Yongqian Shu, Gentao Liu, Peng Zhang, Huijun Zhang, Liang Tang, Yaoqin Yang and Chunlian Wu and has published in prestigious journals such as PLoS ONE, Cancer Letters and Journal of Cellular Biochemistry.

In The Last Decade

Xiaofeng Chen

11 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Chen China 10 393 386 62 34 30 12 514
Stine Jørgensen Denmark 7 689 1.8× 413 1.1× 109 1.8× 35 1.0× 33 1.1× 9 792
Yifeng Cui China 9 311 0.8× 281 0.7× 61 1.0× 69 2.0× 67 2.2× 20 494
Marco Pieraccioli Italy 15 407 1.0× 172 0.4× 94 1.5× 18 0.5× 48 1.6× 20 539
Yuanyuan Ban China 11 518 1.3× 426 1.1× 101 1.6× 36 1.1× 43 1.4× 11 690
Chengdong Qin China 10 358 0.9× 303 0.8× 105 1.7× 32 0.9× 45 1.5× 19 545
Rosemary E. Teresi United States 7 335 0.9× 227 0.6× 61 1.0× 45 1.3× 31 1.0× 10 494
Chengling Zhao China 15 447 1.1× 326 0.8× 129 2.1× 24 0.7× 85 2.8× 20 592
Tao Hai China 12 314 0.8× 234 0.6× 107 1.7× 34 1.0× 35 1.2× 17 523
M M Vleugel Netherlands 5 298 0.8× 251 0.7× 135 2.2× 30 0.9× 40 1.3× 6 444

Countries citing papers authored by Xiaofeng Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Chen more than expected).

Fields of papers citing papers by Xiaofeng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Chen. The network helps show where Xiaofeng Chen may publish in the future.

Co-authorship network of co-authors of Xiaofeng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Chen. A scholar is included among the top collaborators of Xiaofeng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Chen. Xiaofeng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Wang, Yiqing, et al.. (2018). miR‐130 aggravates acute myocardial infarction‐induced myocardial injury by targeting PPAR‐γ. Journal of Cellular Biochemistry. 119(9). 7235–7244. 44 indexed citations
3.
Chen, Xiaofeng, et al.. (2018). MicroRNA-214 inhibits the proliferation and invasion of lung carcinoma cells by targeting JAK1.. PubMed. 10(4). 1164–1171. 20 indexed citations
4.
Han, Xue, et al.. (2018). Implication of serum microRNA-7a/B with myocardial cell injury induced by ischemia reperfusion. Biomedical Research - India. 29(10). 2 indexed citations
5.
Chen, Xiaofeng, Kun Liu, Ping Yang, et al.. (2018). microRNA‑200a functions as a tumor suppressor by targeting FOXA1 in glioma. Experimental and Therapeutic Medicine. 17(1). 221–229. 11 indexed citations
6.
Xu, Dan, Xiaofeng Chen, Quanyong He, & Chengqun Luo. (2016). MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1. OncoTargets and Therapy. Volume 9. 7047–7057. 20 indexed citations
7.
Wang, Rong, Xiaofeng Chen, & Yongqian Shu. (2015). Prediction of non-small cell lung cancer metastasis-associated microRNAs using bioinformatics.. PubMed. 5(1). 32–51. 44 indexed citations
8.
Yang, Guang, Dayong Han, Xin Chen, et al.. (2014). MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo. Neuro-Oncology. 16(5). 652–661. 50 indexed citations
9.
Zhao, Shiguang, Huailei Liu, Yaohua Liu, et al.. (2013). miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells. Cancer Letters. 333(2). 253–260. 70 indexed citations
10.
Wang, Heyong, Yingchao Zhu, Mingchuan Zhao, et al.. (2013). miRNA-29c Suppresses Lung Cancer Cell Adhesion to Extracellular Matrix and Metastasis by Targeting Integrin β1 and Matrix Metalloproteinase2 (MMP2). PLoS ONE. 8(8). e70192–e70192. 109 indexed citations
11.
Zhang, Hui, Mingchuan Zhao, Zhongwei Lv, et al.. (2013). MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer. Cellular Physiology and Biochemistry. 31(1). 56–65. 113 indexed citations
12.
Yang, Haihua, Xiaofeng Chen, Wei Hu, et al.. (2009). Lipoprotein(a) level and its association with tumor stage in male patients with primary lung cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 47(4). 452–7. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026